Cochrane Abstracts
Efavirenz or nevirapine in three‐drug combination therapy with two nucleoside or nucleotide‐reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral‐naïve individuals
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Efavirenz or Nevirapine in Three‐drug Combination Therapy With Two Nucleoside or Nucleotide‐reverse Transcriptase Inhibitors for Initial Treatment of HIV Infection in Antiretroviral‐naïve Individuals." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439305/all/Efavirenz_or_nevirapine_in_three‐drug_combination_therapy_with_two_nucleoside_or_nucleotide‐reverse_transcriptase_inhibitors_for_initial_treatment_of_HIV_infection_in_antiretroviral‐naïve_individuals.
Efavirenz or nevirapine in three‐drug combination therapy with two nucleoside or nucleotide‐reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral‐naïve individuals. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439305/all/Efavirenz_or_nevirapine_in_three‐drug_combination_therapy_with_two_nucleoside_or_nucleotide‐reverse_transcriptase_inhibitors_for_initial_treatment_of_HIV_infection_in_antiretroviral‐naïve_individuals. Accessed March 15, 2025.
Efavirenz or nevirapine in three‐drug combination therapy with two nucleoside or nucleotide‐reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral‐naïve individuals. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439305/all/Efavirenz_or_nevirapine_in_three‐drug_combination_therapy_with_two_nucleoside_or_nucleotide‐reverse_transcriptase_inhibitors_for_initial_treatment_of_HIV_infection_in_antiretroviral‐naïve_individuals
Efavirenz or Nevirapine in Three‐drug Combination Therapy With Two Nucleoside or Nucleotide‐reverse Transcriptase Inhibitors for Initial Treatment of HIV Infection in Antiretroviral‐naïve Individuals [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439305/all/Efavirenz_or_nevirapine_in_three‐drug_combination_therapy_with_two_nucleoside_or_nucleotide‐reverse_transcriptase_inhibitors_for_initial_treatment_of_HIV_infection_in_antiretroviral‐naïve_individuals.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Efavirenz or nevirapine in three‐drug combination therapy with two nucleoside or nucleotide‐reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral‐naïve individuals
ID - 439305
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439305/all/Efavirenz_or_nevirapine_in_three‐drug_combination_therapy_with_two_nucleoside_or_nucleotide‐reverse_transcriptase_inhibitors_for_initial_treatment_of_HIV_infection_in_antiretroviral‐naïve_individuals
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
